Medicalgorithmics, a Warsaw Stock Exchange-listed developer of innovative cardiology technologies, has entered another technology partnership. Its innovative DRAI algorithms and DRP software will be integrated with solutions from the Italian company Accyourate—one of Europe’s leaders in wearable healthcare. This collaboration aligns with the global trend of rapid growth in remote patient monitoring, cardiac prevention, and the decentralization of diagnostic services, strengthening both companies’ positions in the European digital health market. Accyourate’s ambition is to engage hundreds of thousands of patients with its integrated solution. Under the agreement, the Company will receive minimum monthly revenue, and the partner plans and aims to process a significant volume of tests using Medicalgorithmics’ technology.
Accyourate is an innovative Italian medtech company specializing in solutions in the areas of wearable healthcare, remote patient monitoring, and AI-powered physiological data analysis. The company is developing a modern platform based on smart textile sensors and cloud solutions that enable continuous monitoring of vital signs, including ECG signals, in a telemedicine model.
– The collaboration between Accyourate and Medicalgorithmics creates a powerful strategic combination of our respective expertise. Our Italian partner brings cutting-edge wearable technology and expertise in digital patient monitoring, while Medicalgorithmics provides advanced AI algorithms for ECG signal analysis, years of clinical experience, and a scalable, medical-grade diagnostic platform. I am confident that together with Accyourate, we will take home patient care to an even higher level – comments Dr. Kris Siemionow, CEO of Medicalgorithmics.
The combination of both companies’ technologies could enable the creation of a comprehensive, next-generation solution for the remote cardiac diagnostics and telemedicine market, encompassing both the acquisition of biological data and its advanced, AI-supported diagnostic analysis. Given the global nature of the agreement, this collaboration will enable Medicalgorithmics’ software and algorithms to assist patients in Italy, Switzerland, the United Kingdom, the Benelux countries, and the Balkans.